Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2026 Earnings Call Transcript May 12, 2026
Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.33, expectations were $-0.62.
Operator: Good day, and welcome to the Q1 2026 Harvard Biosciences, Inc. Earnings Conference Call. [Operator Instructions] Please note, this call is being recorded. I would now like to turn the call over to Taylor Krafchik, Senior Vice President at Ellipsis TA. Please go ahead.
Taylor Krafchik: Thank you,...
